Michel Degueldre

Michel Degueldre

Company: UCB

Job title: Lead Gene Therapy Biophysical Sciences

Seminars:

Addressing Challenges in the Characterisation & Stability of AAV Vectors – A Biophysical Perspective 2:30 pm

Examine the essential biophysical methods for evaluating AAV vectors in early clinical stages, focusing on determining full and empty particle ratios and selecting the appropriate techniques based on sample quality and development phase Discuss insights into choosing the right biophysical techniques based on specific sample conditions, highlighting the importance of monitoring Elaborate on regulatory aspects…Read more

day: Day One

Strategic Assay Development: When to Invest, Implement, & Innovate Advanced Analytical Methods in Cell & Gene Therapy 9:00 am

This workshop explores the integration of advanced analytical methods, such as NGS, ddPCR, and mass spectometry, into assay development for cell and gene therapies. Gain insights into balancing cost, regulatory requirements, and outsourcing to optimise analytical strategies for innovative therapies. Timing & Cost-Effectiveness: Identify when to integrate advanced assays like NGS, ddPCR, or Raman spectroscopy…Read more

day: Pre-Conference Assay Development Track A - AM

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.